Decipher Labs share price
You have to be logged in to add this to Watchlist.- ₹11.40(-2.48%)April 29, 2025 15:29:02 PM IST
- NSE
- BSE
- Vol : 4.25K (NSE + BSE)Last 20 day avg : 12.89 K
Decipher Labs is trading -2.48% lower at Rs 11.40 as compared to its last closing price. Decipher Labs has been trading in the price range of 11.99 & 11.15. Decipher Labs has given -21.81% in this year & -3.94% in the last 5 days. Decipher Labs has TTM P/E ratio 63.49 as compared to the sector P/E of 26.62.The company posted a net profit of -0.59 Crores in its last quarter.Listed peers of Decipher Labs include Vanta Bioscience (-%), Desh Rakshak Aushdhalaya (4.97%), Decipher Labs (-2.48%).The Mutual Fund holding in Decipher Labs was at -% in . The MF holding has - from the last quarter. The FII holding in Decipher Labs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 29, 2025, 06:51 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.54The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values49.65Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility0.85Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company's revenue fell during December quarter by 29.95% from Rs 8.29 crore to Rs 5.80 crore, year-on-year
- Company has registered a loss of 0.59 cr vs a profit of 0.01 cr in the same quarter last year.
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 12.00
- R2
- 13.50
- R3
- 14.49
- S1
- 9.51
- S2
- 8.52
- S3
- 7.02
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Vanta Bioscience | Bearish | 20.76 | - | 13.10 | - | 0.86 | - | 321.09 |
| Desh Rakshak Aushdhalaya | Neutral | 31.24 | 4.97 | 13.86 | 29.43 | 1.33 | - | 29.33 |
| Decipher Labs | Bearish | 11.40 | -2.48 | 11.50 | - | 0.55 | - | - |
| Beryl Drugs | Bearish | 21.12 | -4.86 | 10.71 | 15.23 | 1.3 | - | 26.94 |
| Unjha Formulations | Neutral | 24.30 | -4.82 | 10.89 | 38.90 | 3.96 | - | - |
- Promoter(s) does not have a high stake in the company
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
| 2024-05-30 | Audited Results |
| 2024-02-14 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE643N01012
- BSE Code524752
- NSE Code
Decipher Labs is trading at 11.40 as on Tue Apr 29 2025 09:59:02. This is -2.48% lower as compared to its previous closing price of 11.69.
The market capitalization of Decipher Labs is 11.50 Cr as on Tue Apr 29 2025 09:59:02.
The 52 wk high for Decipher Labs is 24.60 whereas the 52 wk low is 10.01
Decipher Labs can be analyzed on the following key metrics -
- TTM P/E: 63.49
- Sector P/E: 26.62
- Dividend Yield: 0.00%
- D/E ratio: -
Decipher Labs reported a net profit of -1.68 Cr in 2024.